Pharmaceutical and biotechnology project support

IPT Group provides legal and financial assistance to leading research and pharmaceutical companies in Russia with annual revenue exceeding RUB 4 billion and Skolkovo project members.

We gained unique experience of transferring to Russia technologies for the production of a complete range of essential and vital pharmaceuticals within the government programme for substituting essential and vital imported pharmaceuticals with domestic comparable pharmaceuticals. The company is proud of its successful experience of supporting the operation of the only Russian world-class scientific and research biotechnology centre which carries out research, production and promotion of state-of-the-art biotechnology pharmaceuticals for treating haemophilia, tuberculosis, multiple sclerosis, oncology and cardiovascular diseases.